Details for Patent: 8,039,009
✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Which drugs does patent 8,039,009 protect, and when does it expire?
Patent 8,039,009 protects NAMENDA XR and NAMZARIC and is included in two NDAs.
Protection for NAMENDA XR has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has ten patent family members in nine countries.
Summary for Patent: 8,039,009
|Title:||Modified release formulations of memantine oral dosage forms|
|Abstract:||The present invention provides pharmaceutical compositions given once daily containing at least one therapeutically active ingredient selected from the group consisting of memantine and a pharmaceutically acceptable salt of memantine, and a pharmaceutically acceptable polymeric matrix carrier. The dosage forms of the invention sustain the release of the therapeutically active agent from about 4 to about 24 hours when said dosage form is exposed to aqueous solutions. following entry of said form into a use environment, wherein said dosage form has a dissolution rate of more than about 80% after passage of about 6 hours to about 12 hours following said entry into said use environment.|
|Inventor(s):||Rastogi; Suneel K. (Island Park, NY), Rao; Niranjan (Belle Mead, NJ), Periclou; Antonia (Jersey City, NJ), Abramowitz; Wattanaporn (Hillsborough, NJ), Dedhiya; Mahendra G. (Pomona, NY), Mahashabde; Shashank (Kendall Park, NJ)|
|Assignee:||Forest Laboratories Holdings Limited (BM)|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for patent 8,039,009|
Patent Claim Types:|
see list of patent claims
|Use; Composition; Formulation; Dosage form;|
Drugs Protected by US Patent 8,039,009
International Family Members for US Patent 8,039,009
|Country||Patent Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Australia||2005265031||See Plans and Pricing|
|Brazil||PI0512177||See Plans and Pricing|
|Canada||2569015||See Plans and Pricing|
|China||1968684||See Plans and Pricing|
|Eurasian Patent Organization||011446||See Plans and Pricing|
|Eurasian Patent Organization||200700049||See Plans and Pricing|
|European Patent Office||1781261||See Plans and Pricing|
|>Country||>Patent Number||>Estimated Expiration||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration|